Clinical Trials
15
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine
- Conditions
- Vaccine ReactionVaccination; InfectionInfluenza, HumanInfluenza Viral InfectionsInfluenza
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2023-05-22
- Target Recruit Count
- 450
- Registration Number
- NCT05869201
- Locations
- 🇷🇺
Federally Funded Healthcare Institution Primary Healthcare Unit No. 163,of Federal Medical and Biologic Agency (FFHI PHU No. 163, FMBA of Russia), Kol'tsovo, Novosibirsk Region, Russian Federation
🇷🇺Bessalar Clinic. Clinical Trial Center Limited Liability Company (Bessalar Clinic. Clinical Trial Center LLC), Moscow, Russian Federation
🇷🇺Federation (FSBEI of Higher Education "E. A. Wagner PSMU" of the of the Ministry of Health of the Russian Federation), Perm, Russian Federation
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children
- Conditions
- InfluenzaVaccine ReactionInfluenza, HumanInfluenza Viral Infections
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-08-30
- Target Recruit Count
- 948
- Registration Number
- NCT05739474
- Locations
- 🇷🇺
State Autonomous Health Care Institution of the Sverdlovsk Region "Children's City Clinical Hospital No. 11", Ekaterinburg, Russian Federation
🇷🇺State Autonomous Health Care Institution "Engels City Clinical Hospital No1", Engel's, Russian Federation
🇷🇺Llc "Olla-Med", Moscow, Russian Federation
Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older
- Conditions
- COVID-19Coronavirus InfectionsCOVID-19 Respiratory InfectionRespiratory Tract Infections
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2023-08-30
- Target Recruit Count
- 16304
- Registration Number
- NCT05726084
- Locations
- 🇷🇺
Limited Liability Company "OLLA-MED", Moscow, Russian Federation
🇷🇺State budgetary health care institution of the city of Moscow "City Clinical Hospital No. 24 of the Department of Health of the City of Moscow", Moscow, Russian Federation
🇷🇺Limited Liability Company "Scientific Research Center Eco-Safety", Saint Petersburg, Russian Federation
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
- Conditions
- VaccinesInfluenza, HumanVaccination; Infection
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2022-07-22
- Target Recruit Count
- 1066
- Registration Number
- NCT05470582
- Locations
- 🇷🇺
LLC "Energiya zdorov'ya", Saint Petersburg, Russian Federation
🇷🇺St. Petersburg State Budgetary Institution of Health Care "Children's City Polyclinic No. 45" of the Nevsky District, Saint Petersburg, Russian Federation
Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women
- Conditions
- Influenza, HumanVaccinesVaccination; Infection
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2022-07-14
- Target Recruit Count
- 207
- Registration Number
- NCT05457894
- Locations
- 🇷🇺
Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation, Barnaul, Altai Territory, Russian Federation
🇷🇺Federal State Budgetary Institution "Siberian Federal Scientific and Clinical Center of Federal Medical and Biologic Agency", Seversk, Tomsk Region, Russian Federation
🇷🇺Municipal Budgetary Institution "Central City Hospital No.7", Ekaterinburg, Russian Federation
- Prev
- 1
- 2
- 3
- Next